Patent Analysis of Four <i>Lamiaceae</i>-Derived Plants: A Medicinally Active Resource against New Health Challenges

This study aims to analyze the patent documents concerning the uses of medicinally active plants (MAPs) in relation to COVID-19 during the last four years. Hereinafter, we demonstrate that MAPs, such as those in the <i>Lamiaceae</i> family, can be a fast, healthy, and efficient recourse...

Full description

Bibliographic Details
Main Authors: Reda El Boukhari, Ahmed Fatimi
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Medical Sciences Forum
Subjects:
Online Access:https://www.mdpi.com/2673-9992/21/1/1
_version_ 1827573914045251584
author Reda El Boukhari
Ahmed Fatimi
author_facet Reda El Boukhari
Ahmed Fatimi
author_sort Reda El Boukhari
collection DOAJ
description This study aims to analyze the patent documents concerning the uses of medicinally active plants (MAPs) in relation to COVID-19 during the last four years. Hereinafter, we demonstrate that MAPs, such as those in the <i>Lamiaceae</i> family, can be a fast, healthy, and efficient recourse for designing new drugs or compositions to face new health challenges such as the COVID-19 pandemic. The patent documents concerning sage (<i>Salvia</i>), basil (<i>Ocimum</i>), lavender (<i>Lavandula</i>), and marjoram (<i>Origanum</i>) were searched through different specialized databases by using relevant keywords, and the search was performed on the titles, abstracts, and claims. The state of the art in the field was established by extracting data related to publication dates, patent families, patent classifications, applicants, and jurisdictions from the patent documents. Since the advent of the COVID-19 pandemic, about a hundred patent documents linking the studied plants to the coronavirus have been found. Through our case study, we found that most of the patent applications were filed under international jurisdiction by pharmaceutical companies as applicants. Based on the patent classification, most of the claimed inventions are indeed medicinal preparations characterized by being made with <i>Lamiaceae</i> or having antiviral activities. Finally, the relevant patent documents demonstrate a particular interest in the valorization of bioactive compounds derived from <i>Lamiaceae</i> to improve human defense mechanisms as well as compositions or methods for treating and preventing a coronavirus infection. However, the <i>Salvia</i> genus is the most useful for preventing and/or curing SARS-CoV-2 infection.
first_indexed 2024-03-08T20:28:54Z
format Article
id doaj.art-50d8c6ae08a94dd090cdaf85368afa60
institution Directory Open Access Journal
issn 2673-9992
language English
last_indexed 2024-03-08T20:28:54Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Medical Sciences Forum
spelling doaj.art-50d8c6ae08a94dd090cdaf85368afa602023-12-22T14:28:38ZengMDPI AGMedical Sciences Forum2673-99922023-03-01211110.3390/ECB2023-14093Patent Analysis of Four <i>Lamiaceae</i>-Derived Plants: A Medicinally Active Resource against New Health ChallengesReda El Boukhari0Ahmed Fatimi1Chemical Science and Engineering Research Team (ERSIC), Department of Chemistry, Polydisciplinary Faculty of Beni Mellal (FPBM), Sultan Moulay Slimane University (USMS), Mghila, P.O. Box 592, Beni Mellal 23000, MoroccoChemical Science and Engineering Research Team (ERSIC), Department of Chemistry, Polydisciplinary Faculty of Beni Mellal (FPBM), Sultan Moulay Slimane University (USMS), Mghila, P.O. Box 592, Beni Mellal 23000, MoroccoThis study aims to analyze the patent documents concerning the uses of medicinally active plants (MAPs) in relation to COVID-19 during the last four years. Hereinafter, we demonstrate that MAPs, such as those in the <i>Lamiaceae</i> family, can be a fast, healthy, and efficient recourse for designing new drugs or compositions to face new health challenges such as the COVID-19 pandemic. The patent documents concerning sage (<i>Salvia</i>), basil (<i>Ocimum</i>), lavender (<i>Lavandula</i>), and marjoram (<i>Origanum</i>) were searched through different specialized databases by using relevant keywords, and the search was performed on the titles, abstracts, and claims. The state of the art in the field was established by extracting data related to publication dates, patent families, patent classifications, applicants, and jurisdictions from the patent documents. Since the advent of the COVID-19 pandemic, about a hundred patent documents linking the studied plants to the coronavirus have been found. Through our case study, we found that most of the patent applications were filed under international jurisdiction by pharmaceutical companies as applicants. Based on the patent classification, most of the claimed inventions are indeed medicinal preparations characterized by being made with <i>Lamiaceae</i> or having antiviral activities. Finally, the relevant patent documents demonstrate a particular interest in the valorization of bioactive compounds derived from <i>Lamiaceae</i> to improve human defense mechanisms as well as compositions or methods for treating and preventing a coronavirus infection. However, the <i>Salvia</i> genus is the most useful for preventing and/or curing SARS-CoV-2 infection.https://www.mdpi.com/2673-9992/21/1/1<i>Lamiaceae</i>COVID-19SARS-CoV-2pharmacologyphytotherapyinvention
spellingShingle Reda El Boukhari
Ahmed Fatimi
Patent Analysis of Four <i>Lamiaceae</i>-Derived Plants: A Medicinally Active Resource against New Health Challenges
Medical Sciences Forum
<i>Lamiaceae</i>
COVID-19
SARS-CoV-2
pharmacology
phytotherapy
invention
title Patent Analysis of Four <i>Lamiaceae</i>-Derived Plants: A Medicinally Active Resource against New Health Challenges
title_full Patent Analysis of Four <i>Lamiaceae</i>-Derived Plants: A Medicinally Active Resource against New Health Challenges
title_fullStr Patent Analysis of Four <i>Lamiaceae</i>-Derived Plants: A Medicinally Active Resource against New Health Challenges
title_full_unstemmed Patent Analysis of Four <i>Lamiaceae</i>-Derived Plants: A Medicinally Active Resource against New Health Challenges
title_short Patent Analysis of Four <i>Lamiaceae</i>-Derived Plants: A Medicinally Active Resource against New Health Challenges
title_sort patent analysis of four i lamiaceae i derived plants a medicinally active resource against new health challenges
topic <i>Lamiaceae</i>
COVID-19
SARS-CoV-2
pharmacology
phytotherapy
invention
url https://www.mdpi.com/2673-9992/21/1/1
work_keys_str_mv AT redaelboukhari patentanalysisoffourilamiaceaeiderivedplantsamedicinallyactiveresourceagainstnewhealthchallenges
AT ahmedfatimi patentanalysisoffourilamiaceaeiderivedplantsamedicinallyactiveresourceagainstnewhealthchallenges